---
title: 'Optimal Treatment Strategies for cT2 Staged Adenocarcinoma of the Esophagus
  and the Gastroesophageal Junction: A Multinational, High-volume Center Retrospective
  Cohort Analysis'
date: '2024-08-07'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39109441/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240807181614&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Due to unreliable identification of cT2N0 disease, all
  patients should be offered a multimodal therapeutic ...'
disable_comments: true
---
CONCLUSIONS: Due to unreliable identification of cT2N0 disease, all patients should be offered a multimodal therapeutic ...